Engineering Clinical Development for Novel Therapeutics: CGT and Beyond 2025 | 28 May 2025 |

As the cell and gene therapy field continues to mature, many companies face a growing tension between scientific innovation and the realities of clinical development. Unsustainable costs, limited access to specialized expertise and outdated operational models contribute to high failure rates and stalled progress. In this webinar, they will explore a knowledge driven approach to clinical development, drawing on strategies from industries built around shared expertise and agile, on demand support. They will also discuss a real-world case study with a mid-stage oncology cell therapy company, highlighting how rethinking planning, governance and team structure helped navigate key clinical hurdles.

By attending this webinar, you will learn:
• How CGT companies can adopt more adaptive, scalable clinical development models
• Strategies to overcome common operational and compliance challenges
• Lessons from an oncology case study on navigating early-phase clinical transition

2025 Speakers:

Jeffrey Yablon
Head BD and Strategic Operations, Ubuntu Research

Vishal Mehta
CEO, Ubuntu Research